HEADER TRANSFERASE/TRANSFERASE INHIBITOR 27-APR-11 3RQ7 TITLE POLO-LIKE KINASE 1 POLO BOX DOMAIN IN COMPLEX WITH A C6H5(CH2)8- TITLE 2 DERIVATIZED PEPTIDE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE PLK1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: POLO-LIKE KINASE 1, PLK-1, SERINE/THREONINE-PROTEIN KINASE COMPND 5 13, STPK13; COMPND 6 EC: 2.7.11.21; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: C6H5(CH2)8-DERIVATIZED PEPTIDE INHIBITOR; COMPND 10 CHAIN: B; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PLK1, PLK; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES KEYWDS PHOSPHOPEPTIDE BINDING DOMAIN, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR F.LIU,J.-E.PARK,W.-J.QIAN,D.C.LIM,M.GRABER,T.BERG,M.B.YAFFE,K.S.LEE, AUTHOR 2 T.R.BURKE JR. REVDAT 4 10-OCT-12 3RQ7 1 SEQRES HET HETNAM FORMUL REVDAT 4 2 1 HETATM LINK REMARK REVDAT 3 31-AUG-11 3RQ7 1 JRNL REVDAT 2 03-AUG-11 3RQ7 1 JRNL REVDAT 1 20-JUL-11 3RQ7 0 JRNL AUTH F.LIU,J.E.PARK,W.J.QIAN,D.LIM,M.GRABER,T.BERG,M.B.YAFFE, JRNL AUTH 2 K.S.LEE,T.R.BURKE JRNL TITL SERENDIPITOUS ALKYLATION OF A PLK1 LIGAND UNCOVERS A NEW JRNL TITL 2 BINDING CHANNEL. JRNL REF NAT.CHEM.BIOL. V. 7 595 2011 JRNL REFN ISSN 1552-4450 JRNL PMID 21765407 JRNL DOI 10.1038/NCHEMBIO.614 REMARK 2 REMARK 2 RESOLUTION. 1.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VICENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE- REMARK 3 : KUNSTLEVE,LI-WEI HUNG,ROBERT IMMORMINO, REMARK 3 : TOM IOERGER,AIRLIE MCCOY,ERIK MCKEE,NIGEL REMARK 3 : MORIARTY,REETAL PAI,RANDY READ,JANE REMARK 3 : RICHARDSON,DAVID RICHARDSON,TOD ROMO,JIM REMARK 3 : SACCHETTINI,NICHOLAS SAUTER,JACOB SMITH, REMARK 3 : LAURENT STORONI,TOM TERWILLIGER,PETER REMARK 3 : ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 14.80 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.080 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 29160 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.154 REMARK 3 R VALUE (WORKING SET) : 0.152 REMARK 3 FREE R VALUE : 0.190 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990 REMARK 3 FREE R VALUE TEST SET COUNT : 1454 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 14.8151 - 3.3279 1.00 2868 151 0.1630 0.1587 REMARK 3 2 3.3279 - 2.6464 0.99 2813 149 0.1370 0.1829 REMARK 3 3 2.6464 - 2.3133 0.99 2793 148 0.1405 0.1808 REMARK 3 4 2.3133 - 2.1024 1.00 2803 146 0.1327 0.1975 REMARK 3 5 2.1024 - 1.9521 1.00 2797 149 0.1322 0.1786 REMARK 3 6 1.9521 - 1.8372 0.99 2760 144 0.1468 0.2238 REMARK 3 7 1.8372 - 1.7453 0.99 2790 145 0.1476 0.2321 REMARK 3 8 1.7453 - 1.6695 0.98 2746 143 0.1541 0.2123 REMARK 3 9 1.6695 - 1.6053 0.98 2717 143 0.1587 0.2240 REMARK 3 10 1.6053 - 1.5500 0.94 2619 136 0.1755 0.2449 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.50 REMARK 3 B_SOL : 67.20 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : -0.000 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 18.980 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.012 3704 REMARK 3 ANGLE : 1.665 6686 REMARK 3 CHIRALITY : 0.097 273 REMARK 3 PLANARITY : 0.013 536 REMARK 3 DIHEDRAL : 17.020 981 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3RQ7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-MAY-11. REMARK 100 THE RCSB ID CODE IS RCSB065242. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-SEP-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : OSMIC MIRRORS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29160 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.550 REMARK 200 RESOLUTION RANGE LOW (A) : 14.814 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 4.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.55 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.61 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 33.57 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.85 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PBD PROTEIN AT 12 MG/ML IN 10 MM TRIS, REMARK 280 PH 8.0, 0.5 M NACL, 10 MM DTT, 2% DMSO AND 2 MM COMPOUND 4J WAS REMARK 280 MIXED WITH AN EQUAL VOLUME OF RESERVOIR SOLUTION CONSISTING OF REMARK 280 15% (W/V) PEG 3350, 0.1 M GLYCINE, PH 9.0, 300 MM NACL, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 25.60500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1390 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10660 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE C6H5(CH2)8-DERIVATIZED PEPTIDE INHIBITOR IS POLYPEPTIDE, A REMARK 400 MEMBER OF ENZYME INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: C6H5(CH2)8-DERIVATIZED PEPTIDE INHIBITOR REMARK 400 CHAIN: B REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 367 REMARK 465 ALA A 368 REMARK 465 HIS A 369 REMARK 465 MET A 370 REMARK 465 ASP A 371 REMARK 465 CYS A 372 REMARK 465 ASN A 496 REMARK 465 ILE A 497 REMARK 465 THR A 498 REMARK 465 GLU A 501 REMARK 465 GLY A 502 REMARK 465 ASP A 503 REMARK 465 GLU A 504 REMARK 465 LEU A 505 REMARK 465 ALA A 506 REMARK 465 ARG A 507 REMARK 465 SER A 595 REMARK 465 ALA A 596 REMARK 465 SER A 597 REMARK 465 ASN A 598 REMARK 465 ARG A 599 REMARK 465 LEU A 600 REMARK 465 LYS A 601 REMARK 465 ALA A 602 REMARK 465 SER A 603 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 878 O HOH A 898 1.89 REMARK 500 O HOH A 982 O HOH A 987 1.93 REMARK 500 N LEU A 508 O HOH A 986 2.01 REMARK 500 O HOH B 114 O HOH B 115 2.01 REMARK 500 O HOH A 895 O HOH A 896 2.05 REMARK 500 O HOH B 109 O HOH B 116 2.09 REMARK 500 O HOH A 725 O HOH A 876 2.13 REMARK 500 O HOH A 793 O HOH A 797 2.14 REMARK 500 O HOH A 894 O HOH A 932 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 516 NE - CZ - NH1 ANGL. DEV. = 4.2 DEGREES REMARK 500 ARG A 516 NE - CZ - NH2 ANGL. DEV. = -3.4 DEGREES REMARK 500 ARG A 557 NE - CZ - NH1 ANGL. DEV. = -3.1 DEGREES REMARK 500 ARG A 584 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 392 -130.08 -121.75 REMARK 500 TYR A 421 -51.38 -122.73 REMARK 500 ASP A 449 -36.72 -135.05 REMARK 500 LEU A 463 -169.93 -165.87 REMARK 500 LEU A 490 154.65 79.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1Q4K RELATED DB: PDB REMARK 900 RELATED ID: 1UMW RELATED DB: PDB REMARK 900 RELATED ID: 3BZI RELATED DB: PDB REMARK 900 RELATED ID: 3FVH RELATED DB: PDB REMARK 900 RELATED ID: 3HIK RELATED DB: PDB REMARK 900 RELATED ID: 3C5L RELATED DB: PDB DBREF 3RQ7 A 371 603 UNP P53350 PLK1_HUMAN 371 603 DBREF 3RQ7 B 1 7 PDB 3RQ7 3RQ7 1 7 SEQADV 3RQ7 GLY A 367 UNP P53350 EXPRESSION TAG SEQADV 3RQ7 ALA A 368 UNP P53350 EXPRESSION TAG SEQADV 3RQ7 HIS A 369 UNP P53350 EXPRESSION TAG SEQADV 3RQ7 MET A 370 UNP P53350 EXPRESSION TAG SEQRES 1 A 237 GLY ALA HIS MET ASP CYS HIS LEU SER ASP MET LEU GLN SEQRES 2 A 237 GLN LEU HIS SER VAL ASN ALA SER LYS PRO SER GLU ARG SEQRES 3 A 237 GLY LEU VAL ARG GLN GLU GLU ALA GLU ASP PRO ALA CYS SEQRES 4 A 237 ILE PRO ILE PHE TRP VAL SER LYS TRP VAL ASP TYR SER SEQRES 5 A 237 ASP LYS TYR GLY LEU GLY TYR GLN LEU CYS ASP ASN SER SEQRES 6 A 237 VAL GLY VAL LEU PHE ASN ASP SER THR ARG LEU ILE LEU SEQRES 7 A 237 TYR ASN ASP GLY ASP SER LEU GLN TYR ILE GLU ARG ASP SEQRES 8 A 237 GLY THR GLU SER TYR LEU THR VAL SER SER HIS PRO ASN SEQRES 9 A 237 SER LEU MET LYS LYS ILE THR LEU LEU LYS TYR PHE ARG SEQRES 10 A 237 ASN TYR MET SER GLU HIS LEU LEU LYS ALA GLY ALA ASN SEQRES 11 A 237 ILE THR PRO ARG GLU GLY ASP GLU LEU ALA ARG LEU PRO SEQRES 12 A 237 TYR LEU ARG THR TRP PHE ARG THR ARG SER ALA ILE ILE SEQRES 13 A 237 LEU HIS LEU SER ASN GLY SER VAL GLN ILE ASN PHE PHE SEQRES 14 A 237 GLN ASP HIS THR LYS LEU ILE LEU CYS PRO LEU MET ALA SEQRES 15 A 237 ALA VAL THR TYR ILE ASP GLU LYS ARG ASP PHE ARG THR SEQRES 16 A 237 TYR ARG LEU SER LEU LEU GLU GLU TYR GLY CYS CYS LYS SEQRES 17 A 237 GLU LEU ALA SER ARG LEU ARG TYR ALA ARG THR MET VAL SEQRES 18 A 237 ASP LYS LEU LEU SER SER ARG SER ALA SER ASN ARG LEU SEQRES 19 A 237 LYS ALA SER SEQRES 1 B 7 ACE PRO LEU 56A SER TPO NH2 MODRES 3RQ7 56A B 4 HIS 3-(8-PHENYLOCTYL)-L-HISTIDINE MODRES 3RQ7 TPO B 6 THR PHOSPHOTHREONINE HET ACE B 1 3 HET 56A B 4 24 HET TPO B 6 11 HET NH2 B 7 1 HETNAM ACE ACETYL GROUP HETNAM 56A 3-(8-PHENYLOCTYL)-L-HISTIDINE HETNAM TPO PHOSPHOTHREONINE HETNAM NH2 AMINO GROUP HETSYN TPO PHOSPHONOTHREONINE FORMUL 2 ACE C2 H4 O FORMUL 2 56A C20 H29 N3 O2 FORMUL 2 TPO C4 H10 N O6 P FORMUL 2 NH2 H2 N FORMUL 3 HOH *304(H2 O) HELIX 1 1 HIS A 373 SER A 387 1 15 HELIX 2 2 ARG A 396 GLU A 401 5 6 HELIX 3 3 ASP A 402 ILE A 406 5 5 HELIX 4 4 PRO A 469 SER A 471 5 3 HELIX 5 5 LEU A 472 HIS A 489 1 18 HELIX 6 6 LEU A 564 GLY A 571 1 8 HELIX 7 7 CYS A 573 SER A 593 1 21 SHEET 1 A 6 VAL A 411 ASP A 416 0 SHEET 2 A 6 GLY A 422 LEU A 427 -1 O GLY A 424 N VAL A 415 SHEET 3 A 6 VAL A 432 PHE A 436 -1 O GLY A 433 N TYR A 425 SHEET 4 A 6 ARG A 441 LEU A 444 -1 O LEU A 444 N VAL A 432 SHEET 5 A 6 SER A 450 ILE A 454 -1 O GLN A 452 N ILE A 443 SHEET 6 A 6 GLU A 460 THR A 464 -1 O SER A 461 N TYR A 453 SHEET 1 B 6 LEU A 511 ARG A 516 0 SHEET 2 B 6 ALA A 520 LEU A 525 -1 O HIS A 524 N THR A 513 SHEET 3 B 6 VAL A 530 PHE A 534 -1 O GLN A 531 N LEU A 523 SHEET 4 B 6 LYS A 540 CYS A 544 -1 O LEU A 543 N VAL A 530 SHEET 5 B 6 ALA A 549 ILE A 553 -1 O THR A 551 N ILE A 542 SHEET 6 B 6 PHE A 559 ARG A 563 -1 O TYR A 562 N VAL A 550 LINK C ACE B 1 N PRO B 2 1555 1555 1.34 LINK C LEU B 3 N 56A B 4 1555 1555 1.33 LINK C 56A B 4 N SER B 5 1555 1555 1.34 LINK C SER B 5 N TPO B 6 1555 1555 1.34 LINK C TPO B 6 N NH2 B 7 1555 1555 1.35 CRYST1 35.337 51.210 57.963 90.00 101.00 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.028299 0.000000 0.005498 0.00000 SCALE2 0.000000 0.019527 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017575 0.00000